Literature DB >> 10985928

Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.

G N Onuoha1, E K Alpar.   

Abstract

Calcitonin gene-related peptides (CGRP) is a 37 amino acids peptide that has a proliferative effect on human endothelial cells, and is therefore important for the formation of new vessels and wound healing. As indicated by in vitro and animal studies, CGRP is also a potent vasodilator for cutaneous, cerebral, coronary vessels, a bronchoconstrictor and endocrine regulator. Systemic CGRP increase in patients with soft tissue injuries, chronic illness and sepsis, indicates that CGRP may yet be an important peptides in chronic illness. Although CGRP is a potent vasodilator, systemic vascular resistance does not increase in some patients with high CGRP levels. We questioned whether any changes occur in systemic CGRP levels in patients with one of the most common types of bone fractures especially in the elderly. In order to evaluate further the role of this peptide in these patients, a vasoconstictor (Endothelin-1 [ET]) and another sensory neuropeptide (Substance P [SP]) were measured within 24 h of injury. A sample was obtained on admission (day 1) and within 24 h post admission (day 2) in patients with fracture neck of femur (mean age 77.6, +/- 10 years, n = 20) and compared with healthy controls (51, +/- 26.8 years, n = 20). Peptides and hormones were measured by ELISA techniques. Mean (ng/l) CGRP was elevated in patients (day 1 [314 +/- 195] and day2 [209.2 +/- 150]); compared to controls (68.2 +/-31) P<0.005. Endothelin was non-significantly higher in day-2 (day 1 [28.5 +/-31], day2 [37.4 +/-38], controls [24.2 +/-21]) P = NS. SP maintained higher levels within 24 h after injury (day 1 [85.7 +/- 94], and day2 [80.9 +/- 91.8]) compared to controls, P< 0.05. Furthermore, Elastase (a decisive marker for inflammation and infectious complications) was found to be higher in patients being pronounced in day 2 than in day 1 (day 1 [200 +/-136], day2 [139 +/-118]). Creatine kinase and myoglobin were measured and found to be notably higher in patients. These peptides may be yet another group of cytokines playing significant role in immunologic, inflammatory complications or wound healing in this group of patients. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985928     DOI: 10.1054/npep.2000.0803

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

1.  What is the role of bosentan in healing of femur fractures in a rat model?

Authors:  Ali Aydin; Zekai Halici; Erol Akpinar; A Murat Aksakal; Murat Saritemur; Muhammed Yayla; C Semih Kunak; Elif Cadirci; H Tarik Atmaca; S Sena Karcioglu
Journal:  J Bone Miner Metab       Date:  2014-10-09       Impact factor: 2.626

Review 2.  Fracture mortality: associations with epidemiology and osteoporosis treatment.

Authors:  Sebastian E Sattui; Kenneth G Saag
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

3.  The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing.

Authors:  Jessika Appelt; Anke Baranowsky; Denise Jahn; Timur Yorgan; Paul Köhli; Ellen Otto; Saeed Khomeijani Farahani; Frank Graef; Melanie Fuchs; Aarón Herrera; Michael Amling; Thorsten Schinke; Karl-Heinz Frosch; Georg N Duda; Serafeim Tsitsilonis; Johannes Keller
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

4.  Potential mediators of the mortality reduction with zoledronic acid after hip fracture.

Authors:  Cathleen S Colón-Emeric; Peter Mesenbrink; Kenneth W Lyles; Carl F Pieper; Steven Boonen; Pierre Delmas; Erik F Eriksen; Jay Magaziner
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

Review 5.  No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing.

Authors:  Seungyup Sun; Nicklaus H Diggins; Zachary J Gunderson; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena
Journal:  Bone       Date:  2019-11-09       Impact factor: 4.398

6.  Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial.

Authors: 
Journal:  CMAJ       Date:  2013-11-18       Impact factor: 8.262

Review 7.  Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.

Authors:  Ellen Otto; Paul-Richard Knapstein; Denise Jahn; Jessika Appelt; Karl-Heinz Frosch; Serafeim Tsitsilonis; Johannes Keller
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

8.  Clinical implications of serum myoglobin in trauma patients: A retrospective study from a level 1 trauma center.

Authors:  Khalid Ahmed; Husham Abdelrahman; Ayman El-Menyar; Mahmoud Saqr; Ashwin D Silva; Sherif M Alkahky; Jowhara Al Qahtani; Ahammed Mekkodathil; Hassan Al-Thani; Ruben Peralta
Journal:  Int J Crit Illn Inj Sci       Date:  2020-12-29

9.  Is it a matter of time? The effect of transfer time on femur fracture outcomes.

Authors:  Leah E Larson; Melissa L Harry; Paul K Kosmatka; Kristin P Colling
Journal:  Trauma Surg Acute Care Open       Date:  2021-06-17

10.  Estrogen receptors involvement in intervertebral discogenic pain of the elderly women: colocalization and correlation with the expression of Substance P in nucleus pulposus.

Authors:  Xiao-Xing Song; Sheng Shi; Zhen Guo; Xin-Feng Li; Bu-Wei Yu
Journal:  Oncotarget       Date:  2017-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.